PixarBio Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:PixarBio Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10950
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PixarBio Corp (PixarBio), formerly BMP Holdings Inc is a biotechnology company that discovers and develops novel neurological drug delivery systems for postsurgical pain, acute pain, and chronic pain. The company offers research and commercial development of targeted drug delivery systems, biologics and devices to treat Parkinson’s disease, pain, epilepsy, and spinal cord injury. Its lead product platform NeuroRelease facilitated the sustained release of non-addictive and non-opiate drugs in post-operative, acute and chronic pain in pre-clinical models. PixarBio also helps reduce pain signals without impeding locomotion signals. The company has its operations in New Jersey, New York, and New Hampshire, the US. PixarBio is headquartered in Fort Lee, New Jersey, the US.

PixarBio Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PixarBio Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PixarBio Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PixarBio Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PixarBio Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
PixarBio Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PixarBio Corp, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
PixarBio Raises USD7.2 Million in Venture Financing 10
Merger 11
BMP Holdings Merges with PixarBio in Reverse Merger Transaction 11
Equity Offering 12
Pixarbio Raises USD0.4 Million in Private Placement 12
PixarBio Raises USD0.8 Million in Financing 13
PixarBio Raises USD7.2 Million in Private Placement of Shares and Warrants 14
PixarBio Corp – Key Competitors 15
PixarBio Corp – Key Employees 16
PixarBio Corp – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Product News 18
01/27/2017: PixarBio CEO Frank Reynolds to Present NeuroRelease a Morphine Replacement, Non-Opiate, Non Addictive Pain Treatment at the 2017 NobleCon13 Investor Conference in Boca Raton, FL on Monday, January 30, 2017 18
01/09/2017: PixarBio Expands Non-Opiate R&D Portfolio For Pain with Steroid Injections; Collaborates for Clinical cGMP Manufacturing, and Grooms Team For Clinical Studies of NeuroRelease Post-Surgical Pain Treatments 14-Day, 7-Day, and 3-Day 19
01/05/2017: PixarBio CEO Frank Reynolds to Present NeuroRelease a Morphine Replacement, Non-Opiate, Non Addictive Pain Treatment at the 2017 Biotech Showcase in San Francisco 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
PixarBio Corp, Pharmaceuticals & Healthcare, Key Facts 2
PixarBio Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PixarBio Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PixarBio Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PixarBio Corp, Deals By Therapy Area, 2012 to YTD 2018 8
PixarBio Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PixarBio Raises USD7.2 Million in Venture Financing 10
BMP Holdings Merges with PixarBio in Reverse Merger Transaction 11
Pixarbio Raises USD0.4 Million in Private Placement 12
PixarBio Raises USD0.8 Million in Financing 13
PixarBio Raises USD7.2 Million in Private Placement of Shares and Warrants 14
PixarBio Corp, Key Competitors 15
PixarBio Corp, Key Employees 16
PixarBio Corp, Other Locations 17
PixarBio Corp, Subsidiaries 17

List of Figures
PixarBio Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
PixarBio Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
PixarBio Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
PixarBio Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
PixarBio Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PixarBio Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
PixarBio Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PixarBio Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[PixarBio Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mitsubishi Tanabe Pharma Corporation:企業の戦略・SWOT・財務分析
    Mitsubishi Tanabe Pharma Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Tanabe Pharma Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • University of Birmingham-製薬・医療分野:企業M&A・提携分析
    Summary University of Birmingham is an academic research university that offers educational services. The university provides undergraduate, postgraduate, postgraduate research, and distance learning programs. It offers educational courses in various fields including accounting, astronomy, computer …
  • Arch Therapeutics Inc (ARTH):医療機器:M&Aディール及び事業提携情報
    Summary Arch Therapeutics Inc (Arch Therapeutics) is a medical device company that develops self-assembling barrier technologies to improve interventional wound care outcomes. The company offers hemostasis and sealant products to seal and protect leaking and bleeding tissue. It provides intervention …
  • Indianapolis Power & Light Co-エネルギー分野:企業M&A・提携分析
    Summary Indianapolis Power & Light Co (IPL), a subsidiary of IPALCO Enterprises Inc, is an integrated electric utility. The company generates, transmits, distributes, and sells electric energy. It produces electricity from coal, oil, and natural gas sources. IPL owns and operates power plants in Ind …
  • Sinofert Holdings Ltd (297):企業の財務・戦略的SWOT分析
    Sinofert Holdings Ltd (297) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Enel SpA (ENEL):電力:M&Aディール及び事業提携情報
    Summary Enel SpA (Enel) is an integrated electricity and gas company that produces, distributes and trades electricity and natural gas. The group generates electricity using diverse sources of energy such as nuclear, renewables, oil and gas turbine, coal and gas combined cycle. It also focuses on di …
  • Consolidated Edison Company of New York, Inc.-エネルギー分野:企業M&A・提携分析
    Summary Consolidated Edison Company of New York, Inc. (CECONY), a subsidiary of Consolidated Edison, Inc. is an energy utility that generates, transmits and distributes electricity; supplies natural gas; and generates and supplies steam. The company provides electricity and related services in New Y …
  • Lawson Health Research Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Lawson Health Research Institute (Lawson) is a hospital-based research institute that offers educational and research programs. The institute’ services include health research programs, medical research programs, educational research programs, scientific research programs, patient care servi …
  • Insperity Inc (NSP):企業の財務・戦略的SWOT分析
    Insperity Inc (NSP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • BSH Hausgerate GmbH:企業の戦略・SWOT・財務情報
    BSH Hausgerate GmbH - Strategy, SWOT and Corporate Finance Report Summary BSH Hausgerate GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • United Technologies Corp (UTX):企業の財務・戦略的SWOT分析
    United Technologies Corp (UTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Mitobridge Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Mitobridge Inc (Mitobridge), formerly Mitokyne Inc, a subsidiary of Astellas Pharma Inc is a drug development company that discovers and develops small molecule therapeutics that recovers mitochondrial functions. The company develops therapies for rare diseases and expands into more common d …
  • China Petrochemical Development Corporation (1314):企業の財務・戦略的SWOT分析
    China Petrochemical Development Corporation (1314) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Allison Transmission Holdings Inc:企業の戦略・SWOT・財務分析
    Allison Transmission Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Allison Transmission Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Marcegaglia SpA:企業の戦略・SWOT・財務情報
    Marcegaglia SpA - Strategy, SWOT and Corporate Finance Report Summary Marcegaglia SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Silver Fern Farms Limited:企業の戦略的SWOT分析
    Silver Fern Farms Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Calmare Therapeutics Inc (CTTC):企業の財務・戦略的SWOT分析
    Summary Calmare Therapeutics Inc (CTI) is a bio therapeutic company that offers pain mitigation and wound care technologies. The company provides non-pharmacological, non-addictive and non-invasive solution for chronic neuropathic pain and wound care affliction patients. It offers Calmare, a pain th …
  • ATLAS Oil Co:石油・ガス:M&Aディール及び事業提携情報
    Summary ATLAS Oil Co (ATLAS) is an oil and gas company that offers fuel supply and logistic services. The company’s services comprise supply, renewable fuels, bulk fueling, fuel on demand, logistics, fixed price contracts, frac site fueling, emergency refuel, crude hauling, transloading and on-site …
  • Sky Ltd:企業の戦略的SWOT分析
    Sky Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Acadia Pharmaceuticals Inc (ACAD):製薬・医療:M&Aディール及び事業提携情報
    Summary Acadia Pharmaceuticals Inc (Acadia) discovers, develops and commercializes small molecule drugs for the treatment of central nervous system disorders. The company’s lead product Nuplazid (pimavanserin) is an FDA approved drug for the treatment of Parkinson’s disease psychosis. Acadia also de …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆